U.S. Markets closed
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • Dow 30

    33,761.05
    +424.38 (+1.27%)
     
  • Nasdaq

    13,047.19
    +267.27 (+2.09%)
     
  • Russell 2000

    2,016.62
    +41.36 (+2.09%)
     
  • Crude Oil

    91.88
    -2.46 (-2.61%)
     
  • Gold

    1,799.70
    +10.00 (+0.56%)
     
  • Silver

    20.83
    +0.49 (+2.39%)
     
  • EUR/USD

    1.0257
    -0.0068 (-0.6565%)
     
  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     
  • Vix

    19.53
    -0.67 (-3.32%)
     
  • GBP/USD

    1.2139
    -0.0064 (-0.5220%)
     
  • USD/JPY

    133.4800
    +0.4810 (+0.3617%)
     
  • BTC-USD

    24,487.44
    +475.24 (+1.98%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

COVID vaccine manufacturer Moderna’s CEO discusses the company’s Q3 earnings

Moderna CEO Stéphane Bancel discusses the reasons behind the company’s Q3 success, and his anticipations for Q4. Segment originally aired on August 3, 2022.

Video Transcript

STÉPHANE BANCEL: I mean, what I'm seeing is that governments have a lot of confidence in the Moderna technology and vaccine. They are very happy with what the first generation of vaccine has done. They have seen the clinical data on the new generation of vaccine for these policies are still very strong. And so we are seeing very strong demand across the board. And several customers have actually upped their purchase orders in the last few weeks. I anticipate a few more coming as well.

So I think a strong momentum as we go into the fall. And I expect Q4 to be even stronger than Q3 because, as you can imagine, in July, August, people are waiting for the new version. So I think it's going to be earlier, kind of late August, September, and then massive ramp-up into Q4.

[MUSIC PLAYING]